EX-99.1 3 dex991.htm FMC OVERVIEW BY WILLIAM G. WALTER FMC Overview by William G. Walter

EXHIBIT 99.1

 

LOGO

 

[LOGO OF FMC]

 

Credit Suisse First Boston

16th Annual Chemical Conference

 

September 18th, 2003

 

William G. Walter

Chairman, President and CEO


LOGO

 

[LOGO OF FMC]

 

Disclaimer

 

Safe Harbor Statement under the Private Securities

Litigation Reform Act of 1995:

 

These slides and the accompanying presentation contain “forward-looking statements” that represent management’s best judgment as of the date hereof based on information currently available. Actual results of the Company may differ materially from those contained in the forward-looking statements.

 

Additional information concerning factors that may cause results to materially differ from those in the forward-looking statements is contained in the Company’s periodic reports filed under the Securities Exchange Act of 1934, as amended.

 

The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.

 

1


LOGO

 

[LOGO OF FMC]

 

FMC Corporation

 

Diversified chemical company with leading market positions in industrial, consumer and agricultural markets globally

 

($ million, 12/31/02)

 

     FMC

 

Sales:

   $ 1,852.9  

EBITDA:

   $ 313.7  

Margin:

     16.9 %

 

Industrial

Chemicals


   

Specialty

Chemicals


   

Agricultural

Products


 

Sales:

  $ 753.4     Sales:   $ 488.2     Sales:   $ 615.1  

EBITDA:

  $ 130.3     EBITDA:   $ 116.3     EBITDA:   $ 99.0  

Margin:

    17.3 %   Margin:     23.8 %   Margin:     16.1 %

 

2


LOGO

 

[LOGO OF FMC]

 

Industrial Chemicals: Group Overview

 

2002 Consolidated Sales: $753.4 million          

 

[GRAPHICS]

 

Excludes phosphorus chemicals sales at Astaris JV of $445.7 million, largely in North America

 

v   #1 North American manufacturer of soda ash, peroxygens and phosphorus chemicals

 

v   Backward integration into natural resources

 

v   Low-cost, proprietary production technology

 

3


LOGO

 

[LOGO OF FMC]

 

Industrial Chemicals: Financial Performance

 

($ in millions)

 

[GRAPHIC]  

–  ’01-’02 recession and overcapacity

 

–  Capacity mothballs and shutdowns

 

–  Significant cost savings in 2002

 

–  In 2003, weak performance at Astaris to result in lower earnings

 

1Incudes $79.2 million of phosphorus sales prior to formation of Astaris JV.

Note: “EBITDA” defined in Glossary of Financial Terms on the web at http://ir.fmc.com

 

 

4


LOGO

 

[LOGO OF FMC]

 

Industrial Chemicals: Price Recovery

 

Businesses are in various early stages of recovery

 

v   Price recovery in hydrogen peroxide

 

    Volume growth of 2-3% expected in 2003

 

    Effective capacity utilization above 90%

 

    5-cent price increase announcement now in negotiation for 2004

 

v   Improving capacity utilization in soda ash

 

    Volume growth of 2% expected in 2003

 

    Effective capacity utilization above 90%

 

    Industry structure in flux with one producer being acquired by another

 

    Price increase of at least $7 per ton now in negotiation for 2004

 

v   Bottoming in phosphorus chemicals

 

    Volume growth of 2% expected in 2003

 

    Capacity utilization roughly in mid-70 percent range

 

    North American prices have stabilized, albeit at a 4-5% decline vs. 2002

 

    Some selective price increases in specialty grades during 2003

 

 

5


LOGO

 

[LOGO OF FMC]

 

Specialty Chemicals: Group Overview

 

2002 Consolidated Sales: $488.2 million          

 

[GRAPHIC]

 

v  BioPolymer:

      Adds structure, texture and stability to food
        Acts as a binder & disintegrant for dry tablet drugs
        Market leader in each product line

v  Lithium:

      One of two global, integrated manufacturers
        Focus on specialty products – pharmaceuticals and energy storage devices

 

6


LOGO

 

[LOGO OF FMC]

 

Specialty Chemicals: Financial Performance

 

($ in millions)

 

[GRAPHIC]  

–       BioPolymer growth of 5% CGR driven during the ‘00-’02 period

 

–       Decline in lithium sales due to exit of commodity lithium carbonate

 

–       Good growth in 2003 to be highlighted by steady BioPolymer growth and a recovery in lithium

 

Note: “EBITDA” defined in Glossary of Financial Terms on the web at http://ir.fmc.com

 

7


LOGO

[LOGO OF FMC]

 

Specialty Chemicals: Growth Platforms

 

Leading positions in enabling chemistries with high growth rates

 

v   BioPolymer franchises in food ingredients and pharmaceutical formulation:

 

    Leading global position in markets growing at 3-5%: microcrystalline cellulose, carrageenan and alginates

 

    Industry leading formulation expertise

 

    Globally integrated and efficient supply chain

 

    Disproportionately higher share with market innovators

 

v   Leading lithium chemistry position with growth in high value markets:

 

    Specialty polymers: 28% of sales growing at 4-6%

 

    Pharmaceutical synthesis: 26% of sales growing at 7-9%

 

    Energy storage: 17% of sales growing at rates over 10%

 

8


LOGO

[LOGO OF FMC]

 

Agricultural Products: Group Overview

 

2002 Consolidated Sales: $615.1 million

 

[GRAPHIC]

 

v   Manufacturer of proprietary, branded insecticides and herbicides

 

v   Key crops: cotton, corn, rice, cereals and vegetables

v  FMC differentiated by:

  

–  Concentration in insecticides

 

–  Focus on select crops and regions

 

–  Global alliances

 

–  Proprietary technology

         

 

9


LOGO

[LOGO OF FMC]

 

Agricultural Products: Financial Performance

 

($ in millions)

 

[GRAPHIC]  

–       Global crop recession since 1997

 

–       Steady ’00-’02 sales growth in pyrethroid insecticides of 5% CAGR

 

–       Sulfentrazone row crop peak in 2000

 

–       2002 refocusing on insecticides, key crops and select regions

 

–       Modest growth in 2003

 

Note: “EBITDA” defined in Glossary of Financial Terms on the web at http:/ir.fmc.com

 

10


LOGO

[LOGO OF FMC]

 

Agricultural Products: Productivity and Growth

 

Cost reduction and focused R&D to drive earnings growth

 

v   Production outsourcing strategies to continue to result in significant cost savings

 

v   Nearer-term revenue growth to be driven by new labels and promising ISK chemistry:

 

    New labels in core, patented products of bifenthrin, zeta-cypermethrin and carfentrazone

 

    Novel ISK chemistry targeting sucking pests to launch 2005

 

v   In the longer term, promising compounds identified through our genomics-based discovery efforts:

 

    10 insect-active chemistries under evaluation

 

    Several of these new-to-the-world chemistries are now in field testing

 

    Commercial opportunity 5+ years away

 

11


LOGO

[LOGO OF FMC]

 

FMC’s Strengths

 

Great   businesses in a diverse portfolio

 

  v   Leading market positions

 

  v   Global presence

 

  v   Diversified business mix and high-quality customer base

 

  v   Diversified and integrated cost structure

 

  v   Focused R&D and strong applications expertise

 

  v   Proven management with extensive industry experience

 

12


LOGO

[LOGO OF FMC]

 

FMC Valuation

 

For all our strengths, we continue to be grossly undervalued

 

Enterprise Value to Trailing EBITDA*

(as of September 16th, 2003)

 

[GRAPHIC]

 

S&P 400 Chemicals Index Components

 

Source: Bloomberg Financial and SEC Filings

*Reconciliation to GAAP measure available at Conference Calls and Presentations on the web at http:/ir.fmc.com

 

13


LOGO

[LOGO OF FMC]

 

Unlocking Shareholder Value

 

v   Maximize and realize operating leverage

 

v   Create greater financial flexibility

 

v   Focus the portfolio on higher growth businesses

 

14


LOGO

[LOGO OF FMC]

 

Maximize and Realize Operating Leverage

 

Industrial Chemicals price recovery is only a matter of time

 

v   Capacity utilizations continue to tighten following capacity mothballs and steady demand growth

 

v   Price recovery has begun in hydrogen peroxide, and price outlook in soda ash is improving

 

v   Recovery to be enhanced by significant cost reductions taken in both the U.S. and Europe (Foret)

 

v   Timing of recovery to take several years

 

15


LOGO

[LOGO OF FMC]

 

Maximize and Realize Operating Leverage

 

About ~1 cent per lb. increase in hydrogen peroxide has been achieved in 2003; several more cents possible in 2004

 

[GRAPHIC]

 

16


LOGO

[LOGO OF FMC]

 

Maximize and Realize Operating Leverage

 

Soda ash price announcements for 2004 have begun; consolidation continues with Solvay’s acquisition of American Soda

 

[GRAPHIC]

 

Source: Isonex/USGS and FMC

 

17


LOGO

[LOGO OF FMC]

 

Creating Greater Financial Flexibility

 

v   Reduce working capital by at least $25-30 million in 2003

 

v   Manage capital expenditures at or below D&A

 

v   Generate strong free cash flow beginning in 2004

 

v   Reduce net debt by $300 million by the end of 2006

 

18


LOGO

[LOGO OF FMC]

 

Creating Greater Financial Flexibility

 

Very little free cash flow to reduce debt in 2003, but significant free cash possible in 2004 and beyond

 

    

2003


  

2004


  

2005


  

2006


Expected EBITDA*

   ~$300    --------Increasing------®

Pre-Tax Interest**

   $100    -------Decreasing------®

Capital Expenditures

   $  85    -----Relatively Flat----®

Legacy Environmental

   $  25    ~25    ~25    ~25

Restructuring (Pocatello)

   $  20    ~15    ~15    ~15

Tg Acquisition Payment

   $  35    0    0    0

Astaris Keepwells

   $  60    TBD    0    0

 

*   Reconciliation to GAAP measure available at Conference Calls and Presentations on the web at http://ir.fmc.com
**   Includes Astaris interest

 

19


LOGO

[LOGO OF FMC]

 

Creating Greater Financial Flexibility

 

Restructuring and refinancing the Astaris JV

 

v   Weak Astaris performance in 2003 despite cost savings

 

    Lower sales due principally to 4-5% drop in selling prices

 

    Lack of a $25 million power resale benefit ($12.5 million to FMC)

 

    Over $40 million decline in operating profit ($20 million to FMC)

 

[GRAPHIC]

 

v   Significant asset and portfolio rationalization opportunities exist to create improved business in 2004

 

 

20


LOGO

[LOGO OF FMC]

 

Focus the Portfolio on Higher Growth Businesses

 

Key metrics: profit contribution, return on capital and sales growth

 

[GRAPHIC]

 

Note: “EBIT” and “Capital Employed” defined in Glossary of Financial Terms on the web at http://ir.fmc.com

 

21


LOGO

[LOGO OF FMC]

 

Focus the Portfolio on Higher Growth Businesses

 

v   Growing Specialty Chemicals

 

v   Maintaining and enhancing value of Ag Products business

 

v   Managing Industrial Chemicals for cash

 

   

$’s R&D


 

Licensing/

Partnering


 

$’s Cap.

Expend.


 

Bolt-on

Acq(s).


Spec. Chemicals

  Increase   Yes   ³D&A   Yes

Ag. Products

  Increase   Yes   << D&A   No

Ind. Chemicals

  Flat-to-lower   No   £D&A   No

 

22


LOGO

[LOGO OF FMC]

 

Focus the Portfolio on Higher Growth Businesses

 

Opportunistically manage the portfolio to achieve focus

 

v   Dispose of product lines, markets or divisions consistently performing below the cost of capital

 

v   Divest those businesses in which another company places a higher value

 

23


LOGO

[LOGO OF FMC]

 

Significant Earnings Leverage

 

FMC strategies to add $4 per share to today’s trough levels

 

v   Recovery in Industrial Chemicals

 

v   Growth in Agricultural Products and Specialty Chemicals

 

v   Debt reduction of $300 million by the end of 2006

 

[GRAPHIC]

 

24


LOGO

[LOGO OF FMC]